Aneurysm (6) | ![]() |
Arrhythmia (15) | ![]() |
Cardiovascular disease (72) | ![]() |
Heart attack (88) | ![]() |
Heart disease (98) | ![]() |
Heart failure (48) | ![]() |
Hypertension (31) | ![]() |
Hypoxia (15) | ![]() |
Thrombosis (17) | ![]() |
of heart failure due to systolic dysfunction, being responsible for 10 000 deaths per year in Europe, and it is the most common indication for cardiac transplantation in adolescents and adults.
#Freedom Driver allows man with artificial heart to await transplant at home Heart failure patients awaiting organ transplants normally find themselves anchored to the hospital bed by a washing machine-sized device that keeps blood pumping through their veins.
This organ shortage means that sufferers of advanced heart failure are implanted with devices to aid in survival.
they have largely been used to target life-threatening problems such as heart failure. Stanford Helen Blau, director of the Baxter Laboratory for Stem Cell biology, studies a more banal
and patients often die of heart failure by their teenage years. One in four million children suffer from HGPS,
#Researchers Identify Protein That Opens the Door to Cell Death Findings could aid development of novel therapeutics for conditions ranging from heart failure and stroke to cancer and neurodegeneration.
Dr. Madesh also explained that the new findings could aid the development of novel therapeutics for conditions ranging from heart failure and stroke to cancer and neurodegeneration all of
"An abnormal Q wave indicates the presence of previous myocardial infarction or serious myocardial injury responsible for low cardiac output, heart failure and/or potentially fatal arrhythmias.
Cardiac function assessment for heart failure, coronary angiography for ischaemic heart disease and Holter ECG monitoring for lethal arrhythmias can identify the type of myocardial injury
"An abnormal Q wave indicates the presence of previous myocardial infarction or serious myocardial injury responsible for low cardiac output, heart failure and/or potentially fatal arrhythmias.
Cardiac function assessment for heart failure, coronary angiography for ischaemic heart disease and Holter ECG monitoring for lethal arrhythmias can identify the type of myocardial injury
"Suppose you have a 60-year-old patient who comes in with heart failure, "he said."
Aortic stenosis can lead to heart failure and death. About 100,000 people in the United states have aortic stenosis a
as muscle wasting is associated also with other serious illnesses such as HIV/AIDS, heart failure, rheumatoid arthritis and chronic obstructive pulmonary disease and is also a prominent feature of aging."
ranging from 5 to 15 per cent in chronic heart failure and COPD, and from 60 to 80 per cent in advanced cancer.
and this may lead to congestive heart failure or it may worsen an existing heart failure. Pioneered by Associate professor Leo Hwa Liang from the Department of Biomedical engineering at NUS'Faculty of engineering
Cardiac experts find novel approach to treat heart failure A teenage girl faced with sudden rapid heart deterioration,
a man in the prime years of his life suffering from debilitating heart failure and a former NFL athlete crippled by end-stage heart failure were treated all successfully with a surgical approach pioneered by cardiac experts at University of California, San diego School of medicine.
The work, recently published in The Annals of Thoracic Surgery, demonstrated significant benefits of implanting a left ventricular assist device (LVAD) in the right atrium to provide better blood flow through the lungs,
and death for a person waiting for a transplant or suffering from advanced heart failure.""An LVAD relieves symptoms,
Professor Thomas said. ut a common end result of this compensatory growth is eventual heart failure, a major cause of death in Australia. uring laboratory tests,
stroke and heart failure. igh blood pressure affects even more people at least 4. 6 million Australians. onfirming this connection reliably provides new hope for those people
saving the lives of people who would otherwise die from heart failure. In the U s. about 2, 400 heart transplant occur each year,
#New device for heart failure safely improves heart function, quality of life, study shows A new implantable device to control heart failure is showing promising results in the first trial to determine safety and effectiveness in patients according to lead researcher Dr. William Abraham of The Ohio State university Wexner
Medical center. Results of the study are published in the Journal of American College of Cardiology Heart failure.
Heart failure is one of the fastest growing forms of heart disease and it's one of the most common reasons people are hospitalized said Abraham director of the Division of Cardiovascular Medicine at Ohio State's Wexner Medical center.
The optimal drug therapies we have today often aren't enough to manage this disease for some patients
In the pilot study 20 patients with New york Heart Association (NYHA) functional class III or ambulatory functional class IV heart failure were implanted with the device.
At the one year mark three of the patients had mild or no symptoms of heart failure.
I effectively reversing their heart failure Abraham said. Additionally patients were able to walk an average 100 feet farther during standardized measures
Drug and device therapies that are currently available for heart failure improve that same quality of life score by only five or 10 points.
which means they are at high risk for stroke heart failure and kidney failure he says. Implanted electrical devices that control bodily functions have been used for many years.
Wireless Monitoring Sensor to Help Manage Heart failure Scott & White Memorial is one of six hospitals in Texas
click New Tech Helping Heart failure Patientse are always looking for new and innovative ways to treat our patient disease process
and improve outcomes for heart failure patients, said Robert Scott III, MD, Director for Advanced Heart failure at Scott & White Memorial. his device will give us the ability to anticipate problems with our patients before they occur,
decreasing their chance of being readmitted to the hospital, and improving their quality of life. emorial implemented the Cardiomems HF System
which is the first and only FDA-approved heart failure monitoring device proven to significantly reduce hospital admissions.
which are used traditionally as indirect measures of worsening heart failure. The new system allows patients to transmit daily sensor readings from their homes to their health care providers allowing for personalized
According to the Centers for Disease Control and Prevention, more than 5. 1 million Americans have heart failure
Patients with heart failure are hospitalized frequently, have reduced a quality of life and face a higher risk of death.
US researchers have found that peat fires in the southern states during the summer of 2008 caused a spike in emergency room visits for heart failure and asthma-related respiratory complications.
Patients most at risk are those with chronic kidney disease combined with diabetes and hypertension or heart failure.
Thirty-five percent of patients also suffered from heart failure. Depending on the severity of their hyperkalemia
The combination of chronic kidney disease, type 2 diabetes, high blood pressure, hyperkalemia and, in about one-third of cases, heart failure, can be deadly.
and evaluate aldosterone blockade in heart failure patients.""Previous research demonstrated the short-term benefits of patiromer,
Confronted with a rare and particularly difficult case of congenital heart failure, Richard Kim, MD, from the Children Hospital of Los angeles (CHLA) took a step forward
however, promises to benefit a high number of patients with heart failure or rhythm abnormalities that complicate sepsis.
Bone marrow-derived autologous human mesenchymal stem cells (MSCS) are one of the most promising cell sources for cell therapy to treat heart failure.
< Back - Next >
Overtext Web Module V3.0 Alpha
Copyright Semantic-Knowledge, 1994-2011